Company intelligence / Profile preview

Frontage Laboratories

Exton, Pennsylvania, United States

Ownership: Private
Employees: ~1800
Development stage: Other

Overview

Frontage Laboratories is a US-based global contract research, development, and manufacturing organization (CRDMO) offering end-to-end support from drug discovery, preclinical, IND-enabling, clinical, and CMC, to manufacturing, with capabilities for both small molecules and biologics. The company is not a product innovator and does not advance own clinical assets or own a proprietary clinical-stage pipeline. It supports client molecules which have advanced through IND, NDA, ANDA, and BLA filings, and through clinical stages to commercial launch in multiple markets, including the US, EU, and China.

Modalities: Small moleculeBiologicGene therapyCell therapyAntisense oligonucleotideProteinPeptides
Industry: Drug Discovery Services

Partnerships

EPNextS GroupFanghui

Beyond the preview

Go deeper on Frontage Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontage Laboratories.

Explore the full profile